Science

Bibi Maryam: The prognostic role of ctDNA clearance in localized and metastatic RCC

Bibi Maryam/X

Feb 12, 2025, 15:01

Bibi Maryam: The prognostic role of ctDNA clearance in localized and metastatic RCC

Bibi Maryam, Resident Physician at University of Oklahoma, shared an article by Adanma Ayanambakkam, et al. on X:

“Excited to share our abstract on the prognostic role of circulating tumor DNA (ctDNA) clearance as a biomarker in localized and metastatic renal cell carcinoma for ⁦ASCO GU25.

Grateful to work with⁦⁦ Adanma Ayanambakkam⁩ on this.”

The prognostic role of circulating tumor DNA (ctDNA) clearance as a biomarker in localized and metastatic renal cell carcinoma (RCC): A single-center experience.

Authors: Adanma Ayanambakkam, et al.

Bibi Maryam: The prognostic role of ctDNA clearance in localized and metastatic RCC

Adanma Ayanambakkam ASCO Bibi Maryam cancer Circulating tumor DNA ctDNA fight against cancer Global fight against cancer GU25 OncoDaily Oncology RCC renal cell carcinoma University of Oklahoma

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Special Coverage